Priti Patel
Pediatric Endocrinology · Tucson, AZNPI 1760430391
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 254 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations.
Across 254 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Xeris Pharmaceuticals, Inc.$519
- Arbor Pharmaceuticals, Inc.$512
- Sanofi-aventis U.S. LLC$342
- Ascendis Pharma Endocrinology Inc$260
- Insulet Corporation$247
- Novo Nordisk$230
- plus $3K from 31 others
What the payments were for
- Food & beverage$4,830100%
- Entertainment$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 26 | $519 |
| Arbor Pharmaceuticals, Inc. | 28 | $512 |
| Sanofi-aventis U.S. LLC | 13 | $342 |
| Ascendis Pharma Endocrinology Inc | 10 | $260 |
| Insulet Corporation | 12 | $247 |
| Novo Nordisk | 16 | $230 |
| Lilly USA, LLC | 14 | $218 |
| Ipsen Biopharmaceuticals, Inc | 8 | $210 |
| BETA Bionics, Inc. | 18 | $193 |
| Tolmar, Inc. | 10 | $192 |
| Azurity Pharmaceuticals, Inc. | 9 | $182 |
| AbbVie | 10 | $181 |
| Abbott | 12 | $178 |
| Ultragenyx Pharmaceutical Inc. | 7 | $155 |
| Medtronic(2 entities) | 6 | $148 |
| Tolmar Pharmaceuticals, Inc. | 7 | $128 |
| Tandem Diabetes Care, Inc. | 5 | $114 |
| Ferring Pharmaceuticals Inc. | 5 | $108 |
| Neurocrine Biosciences, Inc. | 3 | $93 |
| Dexcom, Inc. | 6 | $87 |
| BD | 3 | $56 |
| Sequel Med Tech, LLC | 1 | $50 |
| Kyowa Kirin, Inc. | 2 | $49 |
| Amphastar Pharmaceuticals, Inc. | 3 | $45 |
| Eton Pharmaceuticals, Inc. | 1 | $44 |
| Revance Therapeutics, Inc. | 1 | $43 |
| Bayer | 3 | $40 |
| IBSA Pharma Inc. | 3 | $37 |
| Galderma Laboratories, L.p. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $28 |
| Corcept Therapeutics | 1 | $25 |
| Pfizer | 1 | $22 |
| Optos, Inc. | 1 | $22 |
| Regeneron | 1 | $17 |
| Zealand Pharma US, Inc. | 1 | $17 |
| Averitas Pharma Inc. | 1 | $17 |
| Intuity Medical Inc | 1 | $14 |
How this compares
$4,852 in reported general payments places this provider in the 75th percentile of 35 pediatric endocrinology providers in Arizona.
Other pediatric endocrinology in Tucson
- Chetanbabu PatelTucson$7K
- Rishita TiwariTucson$5K
- Mark WheelerTucson$494
- Sunil SinhaTucson$330
- Cindy ChinTucson$181
- Sarah GreenTucson$91
- Eileen Baez IrizarryPhoenix$53K
- Pamela SmithPhoenix$26K
- Chirag KapadiaPhoenix$13K
- Grazyna Piekos-SobczakPhoenix$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.